Download FREE Report Sample
Download Free sampleMedications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
Gastroparesis Drugs Market contains market size and forecasts of Gastroparesis Drugs in global, including the following market information:
Global Gastroparesis Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gastroparesis Drugs Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Gastroparesis Drugs companies in 2021 (%)
The global Gastroparesis Drugs market was valued at 5822.8 million in 2021 and is projected to reach US$ 7722 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prokinetic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gastroparesis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroparesis Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, by Type, 2021 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Gastroparesis Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, by Application, 2021 (%)
Diabetic Gastroparesis
Idiopathic Gastroparesis
Global Gastroparesis Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gastroparesis Drugs revenues share in global market, 2021 (%)
Key companies Gastroparesis Drugs sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Gastroparesis Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
